Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Cancer Prevention Screening topic
No spam. Unsubscribe anytime.
American Cancer Society outlines state priorities: screening, biomarker testing and patient services
Summary
Michael Rollo of ACS CAN briefed the committee on cancer incidence estimates, screening concerns and the society's policy priorities including biomarker testing coverage, paid family leave, tobacco prevention funding and patient services such as Hope Lodge in Burlington.
Michael Rollo, government relations director for the American Cancer Society Cancer Action Network (ACS CAN), told the House Healthcare Committee that cancer prevention, screening and access to care remain top priorities for the organization in Vermont.
Rollo opened with statewide figures: "In 2024, 45,100 Vermonters would be diagnosed with cancer," he said, and added an estimate of deaths: "approximately 1,460 folks will lose their battle to cancer." He said ACS CAN will focus on improving access to biomarker testing, paid family medical leave for patients and caregivers, and funding for cancer-screening programs.
He highlighted two immediate service items: the organization supports funding for the state cancer and screening programs and for the cancer registry, and he noted services the society provides directly, including a Hope Lodge near UVM Medical Center in Burlington that offers free lodging for patients and their caregivers during extended treatment.
Rollo also emphasized tobacco prevention and cessation as the leading preventable cause of cancer and said ACS CAN will advocate for funding and policies to reduce tobacco use, support breast and cervical screening programs, and protect registry funding. He invited committee members to the society's annual Cancer Action Day at the State House on March 18 and described volunteer services such as the Road to Recovery transportation program and support groups.
Rollo said ACS CAN is prepared to work with the committee on legislative proposals and offered to follow up on research and screening utilization questions raised by members.
